Health
Medical
Cancer Prevention

Guardant Health

$93.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (0.14%) Today
$0.00 (0.00%) As of 4:30 PM EDT after-hours

Why Robinhood?

You can buy or sell GH and other stocks, options, ETFs, and crypto commission-free!

About GH

Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in provision of precision oncology testing and development services. Read More It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.

Employees
454
Headquarters
Redwood City, California
Founded
2012
Market Cap
8.06B
Price-Earnings Ratio
Dividend Yield
Average Volume
762.13K
High Today
$97.15
Low Today
$93.22
Open Price
$93.88
Volume
483.87K
52 Week High
$106.58
52 Week Low
$27.04

Collections

Health
Medical
Cancer Prevention
2018 IPO
US
North America

GH Earnings

-$1.94
-$1.39
-$0.85
-$0.30
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 15, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.